These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

411 related items for PubMed ID: 25158063

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. FHL-1 is not involved in pressure overload-induced maladaptive right ventricular remodeling and dysfunction.
    Veith C, Neghabian D, Luitel H, Wilhelm J, Egemnazarov B, Muntanjohl C, Fischer JH, Dahal BK, Schermuly RT, Ghofrani HA, Grimminger F, Fink L, Kwapiszewska G, Weissmann N, Sydykov A.
    Basic Res Cardiol; 2020 Jan 24; 115(2):17. PubMed ID: 31980934
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. A Dynamic Sheep Model to Induce Pulmonary Hypertension and Right Ventricular Failure.
    Johnson CA, Cortelli M, Glomp G, Cagnolatti C, Demarest CT, Ukita R, Bacchetta M.
    Methods Mol Biol; 2024 Jan 24; 2803():239-258. PubMed ID: 38676898
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Diffuse right ventricular fibrosis in heart failure with preserved ejection fraction and pulmonary hypertension.
    Patel RB, Li E, Benefield BC, Swat SA, Polsinelli VB, Carr JC, Shah SJ, Markl M, Collins JD, Freed BH.
    ESC Heart Fail; 2020 Feb 24; 7(1):253-263. PubMed ID: 31903694
    [Abstract] [Full Text] [Related]

  • 48. Arterial load and right ventricular-vascular coupling in pulmonary hypertension.
    Oakland H, Joseph P, Naeije R, Elassal A, Cullinan M, Heerdt PM, Singh I.
    J Appl Physiol (1985); 2021 Jul 01; 131(1):424-433. PubMed ID: 34043473
    [Abstract] [Full Text] [Related]

  • 49. PBI-4050 reduces pulmonary hypertension, lung fibrosis, and right ventricular dysfunction in heart failure.
    Nguyen QT, Nsaibia MJ, Sirois MG, Calderone A, Tardif JC, Fen Shi Y, Ruiz M, Daneault C, Gagnon L, Grouix B, Laurin P, Dupuis J.
    Cardiovasc Res; 2020 Jan 01; 116(1):171-182. PubMed ID: 30753422
    [Abstract] [Full Text] [Related]

  • 50. Sildenafil prevents and reverses transverse-tubule remodeling and Ca(2+) handling dysfunction in right ventricle failure induced by pulmonary artery hypertension.
    Xie YP, Chen B, Sanders P, Guo A, Li Y, Zimmerman K, Wang LC, Weiss RM, Grumbach IM, Anderson ME, Song LS.
    Hypertension; 2012 Feb 01; 59(2):355-62. PubMed ID: 22203744
    [Abstract] [Full Text] [Related]

  • 51. Delineating the molecular and histological events that govern right ventricular recovery using a novel mouse model of pulmonary artery de-banding.
    Boehm M, Tian X, Mao Y, Ichimura K, Dufva MJ, Ali K, Dannewitz Prosseda S, Shi Y, Kuramoto K, Reddy S, Kheyfets VO, Metzger RJ, Spiekerkoetter E.
    Cardiovasc Res; 2020 Aug 01; 116(10):1700-1709. PubMed ID: 31738411
    [Abstract] [Full Text] [Related]

  • 52. Pulmonary artery banding is a relevant model to study the right ventricular remodeling and dysfunction that occurs in pulmonary arterial hypertension.
    Akazawa Y, Okumura K, Ishii R, Slorach C, Hui W, Ide H, Honjo O, Sun M, Kabir G, Connelly K, Friedberg MK.
    J Appl Physiol (1985); 2020 Aug 01; 129(2):238-246. PubMed ID: 32644912
    [Abstract] [Full Text] [Related]

  • 53. Functional and molecular determinants of right ventricular response to severe pulmonary hypertension in a large animal model.
    Brown RD, Hunter KS, Li M, Frid MG, Harral J, Krafsur GM, Holt TN, Williams J, Zhang H, Riddle SR, Edwards MG, Kumar S, Hu CJ, Graham BB, Walker LA, Garry FB, Buttrick PM, Lahm T, Kheyfets VO, Hansen KC, Stenmark KR.
    Am J Physiol Heart Circ Physiol; 2023 Jun 01; 324(6):H804-H820. PubMed ID: 36961489
    [Abstract] [Full Text] [Related]

  • 54. Functional and molecular factors associated with TAPSE in hypoxic pulmonary hypertension.
    Crnkovic S, Schmidt A, Egemnazarov B, Wilhelm J, Marsh LM, Ghanim B, Klepetko W, Olschewski A, Olschewski H, Kwapiszewska G.
    Am J Physiol Lung Cell Mol Physiol; 2016 Jul 01; 311(1):L59-73. PubMed ID: 27106290
    [Abstract] [Full Text] [Related]

  • 55. Cardiac Magnetic Resonance Imaging-Based Right Ventricular Strain Analysis for Assessment of Coupling and Diastolic Function in Pulmonary Hypertension.
    Tello K, Dalmer A, Vanderpool R, Ghofrani HA, Naeije R, Roller F, Seeger W, Wilhelm J, Gall H, Richter MJ.
    JACC Cardiovasc Imaging; 2019 Nov 01; 12(11 Pt 1):2155-2164. PubMed ID: 30878422
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Clinical Determinants and Prognostic Implications of Right Ventricular Dysfunction in Pulmonary Hypertension Caused by Chronic Lung Disease.
    Prins KW, Rose L, Archer SL, Pritzker M, Weir EK, Olson MD, Thenappan T.
    J Am Heart Assoc; 2019 Jan 22; 8(2):e011464. PubMed ID: 30646788
    [Abstract] [Full Text] [Related]

  • 59. Ca2+ handling remodeling and STIM1L/Orai1/TRPC1/TRPC4 upregulation in monocrotaline-induced right ventricular hypertrophy.
    Sabourin J, Boet A, Rucker-Martin C, Lambert M, Gomez AM, Benitah JP, Perros F, Humbert M, Antigny F.
    J Mol Cell Cardiol; 2018 May 22; 118():208-224. PubMed ID: 29634917
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.